Researchers have successfully developed a novel drug to restore vision. The treatment method restores vision through retinal nerve regeneration. Vision is one of the most crucial human senses, yet ...

The device could help a million people with a severe form of macular degeneration to be able to see enough to read. By Gina Kolata For the first time, researchers restored some vision to people with a ...

What Is Eylea HD, and Why Does It Matter? Eylea HD (aflibercept) is an injectable medicine used to treat certain eye conditions that can lead to vision loss. It works by blocking a protein called VEGF ...

Vision is one of the most crucial human senses, yet more than 300 million people worldwide are at risk of vision loss due to various retinal diseases. While recent advancements in retinal disease ...

Gene therapy emerges as a transformative force in ophthalmology, offering renewed hope for patients with retinal diseases. This innovative approach targets both inherited and acquired conditions, ...

A tabletop device that delivers various wavelengths of light therapy to the back of the eye to activate cellular function in people with intermediate dry age-related macular degeneration (AMD) ...

Overview of study design and analytical flow for identifying metabolic features associated with anti-VEGF therapy on macular edema (ME) patients (created with BioRender.com). anti-VEGF, anti-vascular ...

A funding shortfall for a key copay assistance program to help make eye injections more affordable for low-income patients has caused widespread disruption in treatment, researchers have found. The ...

For the first time, researchers have restored some vision to people with a common type of eye disease by using a prosthetic retinal implant. If approved for broader use in the future, the treatment ...